Спайдер понижается перед открытием торгов на NYSE.
Европейские индексы на отрицательной территории.
SPY (внутридневной график) снижение движение на премаркете. Сопротивление: 172.20 Поддержка: 171.50
Премаркет NYSE/NASDAQ:
Gapping up:
- In reaction to strong earnings/guidance: TIBX +7.8%, NQ +4.3%, CTAS +3%.
- M&A news: VRNM +58.6% (enters agreement to be acquired by BASF (BASFY) for $4.00 per share in cash).
- Other news: CYCC +35.3% (sapacitabine reported to have anti-tumor activity against ovarian cancer), JKS +6.3% (prices 3.8 mln ADS follow on offering at $16.25), GT +4.4% (reconfirmed its outlook for 2013 segment operating income; Reinstates cash dividend on common stock, announces share repurchase program), NAVB +4.2% (independent investigators reported Lymphoseek results in JAMA Otolaryngology Head and Neck Surgery), TSPT +2.7% (Roumell Asset Management issued letter to Board: 'Retrophin offer of $4 per share is woefully inadequate'), JCP +2.1% (Vornado (VNO) selling 13.4 mln share stake), KIOR +1.7% (provides operational update on Columbus Facility: as of August 31, 2013), AAPL +1.6% (launches iPhone 5s and 5c today), HIMX +1.6% (still checking), SSTK +1.4% (prices 4.6 mln share follow on offering of common stock at $60.00 per share; shares offered by co and selling shareholders), LGF +1.3% (CFO James Keegan retiring, will be succeeded as CFO by former Viacom CFO James Barge), KNDI +1.2% (cont strength).
(
Читать дальше )